- Home
- ATOS vs PVBC Comparison
ATOS vs PVBC Comparison
Compare ATOS & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- PVBC
- Stock Information
- Founded
- ATOS 2009
- PVBC 1913
- Country
- ATOS United States
- PVBC United States
- Employees
- ATOS N/A
- PVBC N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- PVBC Major Banks
- Sector
- ATOS Health Care
- PVBC Finance
- Exchange
- ATOS Nasdaq
- PVBC Nasdaq
- Market Cap
- ATOS 174.8M
- PVBC 187.2M
- IPO Year
- ATOS 2012
- PVBC 2015
- Fundamental
- Price
- ATOS $1.47
- PVBC $10.28
- Analyst Decision
- ATOS Strong Buy
- PVBC Hold
- Analyst Count
- ATOS 3
- PVBC 1
- Target Price
- ATOS $6.25
- PVBC $11.00
- AVG Volume (30 Days)
- ATOS 575.2K
- PVBC 43.7K
- Earning Date
- ATOS 11-12-2024
- PVBC 10-24-2024
- Dividend Yield
- ATOS N/A
- PVBC N/A
- EPS Growth
- ATOS N/A
- PVBC N/A
- EPS
- ATOS N/A
- PVBC 0.42
- Revenue
- ATOS N/A
- PVBC $58,737,000.00
- Revenue This Year
- ATOS N/A
- PVBC N/A
- Revenue Next Year
- ATOS N/A
- PVBC $7.22
- P/E Ratio
- ATOS N/A
- PVBC $24.48
- Revenue Growth
- ATOS N/A
- PVBC 193.04
- 52 Week Low
- ATOS $0.62
- PVBC $7.36
- 52 Week High
- ATOS $2.31
- PVBC $12.32
- Technical
- Relative Strength Index (RSI)
- ATOS 54.46
- PVBC 42.35
- Support Level
- ATOS $1.40
- PVBC $10.61
- Resistance Level
- ATOS $1.58
- PVBC $10.95
- Average True Range (ATR)
- ATOS 0.08
- PVBC 0.34
- MACD
- ATOS -0.00
- PVBC -0.06
- Stochastic Oscillator
- ATOS 52.17
- PVBC 7.02
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.